Citation: G. Dickneite et al., DEVELOPMENT OF AN ANTI-BLEEDING AGENT FOR RECOMBINANT HIRUDIN INDUCEDSKIN BLEEDING IN THE PIG, Thrombosis and haemostasis, 80(1), 1998, pp. 192-198
Citation: G. Dickneite et al., CORRECTION OF RECOMBINANT HIRUDIN INDUCED BLEEDING BY HAEMATE(R) - RESULTS FROM A PIG STUDY, Thrombosis and haemostasis, 1997, pp. 889-889
Citation: J. Kouz et al., INFLUENCE OF RECOMBINANT HIRUDIN ON TISSUE-FACTOR-INDUCED ACTIVATION OF COAGULATION IN RABBITS, Haemostasis, 26(4), 1996, pp. 179-186
Authors:
HEIL G
CHADID L
HOELZER D
SEIPELT G
MITROU P
HUBER C
KOLBE K
MERTELSMANN R
LINDEMANN A
FRISCH J
NICOLAY U
GAUS W
HEIMPEL H
Citation: G. Heil et al., GM-CSF IN A DOUBLE-BLIND RANDOMIZED, PLACEBO-CONTROLLED TRIAL IN THERAPY OF ADULT PATIENTS WITH DE-NOVO ACUTE MYELOID-LEUKEMIA (AML), Leukemia, 9(1), 1995, pp. 3-9
Authors:
LINK H
BRUNE T
HUBNER G
DIEDRICH H
FREUND M
STOLL M
PEEST D
EBELL W
BETTONI C
OSTER W
NICOLAY U
HEINRICHS H
Citation: H. Link et al., EFFECT OF RECOMBINANT-HUMAN-ERYTHROPOIETIN AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION, Annals of hematology, 67(4), 1993, pp. 169-173